Not finding it? Sign in to also search OpenAlex live.
-
Impact of symptom duration on the short- and long-term efficacy of bimekizumab in axial spondyloarthritis: results up to 2 years2026 Arthritis Research & Therapy article Medicine Spondyloarthritis Studies and Treatments Open access
Sofía Ramiro, Fabian Nikolai Proft, Raj Sengupta, Astrid M van Tubergen, Anna Moltó, Lianne S. Gensler, +5 more
3citations -
Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
Antoinette MaassenVanDenBrink, Gisela Marie Terwindt, Joshua M. Cohen, Steve Barash, Verena Ramirez Campos, Maja Galić, +2 more
19citations -
The clinical effectiveness of a self-management intervention for patients with persistent depressive disorder and their partners/caregivers: results from a multicenter, pragmatic randomized controlled trial
Ericka C. Solis, Ingrid V. E. Carlier, Noëlle G. A. Kamminga, Erik J. Giltay, Albert M. van Hemert
3citations -
OR25-05 Clinical Predictors Of Symptomatic Benefit In Men With Low Testosterone During Testosterone Treatment Compared With Placebo: Results Of Individual Patient And Aggregate Data Meta-analyses2023 Journal of the Endocrine Society article Medicine Hormonal and reproductive studies Open access
Jemma Hudson, Moira K Cruickshank, Richard Quinton, Lorna S. Aucott, Frederick C. W. Wu, Mathis Grossmann, +29 more
0citations -
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer2022 Annals of Oncology article Medicine PARP inhibition in cancer therapy Open access cited by 1 patent
Charles E. Geyer, Judy Ellen Garber, Richard D. Gelber, Greg Yothers, L. Ross, Priya Rastogi, +90 more
473citations -
#3345 Nefecon provides kidney benefit irrespective of baseline eGFR in patients with IgAN: a subanalysis of the NefIgArd study2025 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Jonathan Barratt, Richard A. Lafayette, Heather N. Reich, Jens Halkjaer Kristensen, Russell F Jones, Jürgen Floege, +4 more
0citations -
LB1531B. Administration of the TNF-alpha inhibitor, infliximab, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial
Jane A. O’Halloran, Kevin Joseph Anstrom, Eyal Kedar, Matthew William McCarthy, Emily R. Ko, Richard Melsheimer, +4 more
0citations -
Non-steroidal anti-inflammatory drugs for acute gout2021 Cochrane Database of Systematic Reviews article Medicine Gout, Hyperuricemia, Uric Acid Open access
Caroline MPG van Durme, Mihir D. Wechalekar, Robert Landewé, Jordi Pardo Pardo, Sheila Cyril, Désirée M F M van der Heijde, +1 more
44citations -
OP0230 EFFICACY AND SAFETY OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS WHO DEMONSTRATED INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITION: WEEK 24 RESULTS OF A PHASE 3B, RANDOMIZED, CONTROLLED STUDY2021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Laura C. Coates, Laure Gossec, Elke Theander, Paul Bergmans, Marlies Neuhold, Chetan S. Karyekar, +4 more
4citations -
Summary measures in non-inferiority clinical trials with a time-to-event outcome: an empirical comparison of power2025 BMC Medical Research Methodology article Mathematics Statistical Methods in Clinical Trials Open access
Shole D.L. Broer, Ian R. White, Tim Peter Morris, Isabelle R. Weir, Marta F. Fiocco, Matteo Quartagno
0citations -
Effects of linagliptin vs glimepiride stratified by prior insulin secretagogue use in the cardiovascular outcome study of linagliptin versus glimepiride in type 2 diabetes (CAROLINA) trial
Darren K. McGuire, J Rosenstock, Odd-Erik Johansen, Bernard Zinman, Kamlesh K. Khunti, Michaela Mattheus, +3 more
1citations -
Critical appraisal of combination therapies: the impact of trial design on benefit-risk outcomes2026 JNCI Journal of the National Cancer Institute article Mathematics Statistical Methods in Clinical Trials
Floor de Jong, Li-Anne H Douma, Paul Baas, Cornedine Jannette de Gooijer, Hans A. J. Gelderblom, Jacobus A. Burgers, +1 more
0citations -
Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES2022 Canadian Journal of Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access
Chern‐En Chiang, Gregory G. Schwartz, Yedid Elbez, Michael J. Szarek, Deepak L. Bhatt, Vera Bittner, +11 more
14citations